"
Clinicopathological Characteristics of Basal Type Breast Cancer in Triple-Negative Breast Cancer"
written by Goro Kutomi, Tousei Ohmura, Yasuyo Suzuki, Hidekazu Kameshima, Hiroaki Shima, Tomoko Takamaru, Fukino Satomi, Seiko Otokozawa, Mitsuru Mori, Koichi Hirata,
published by
Journal of Cancer Therapy,
Vol.3 No.5A, 2012
has been cited by the following article(s):
|
[1]
|
Analysis of CK5/6 and EGFR and Its Effect on Prognosis of Triple Negative Breast Cancer
Frontiers in Oncology,
2021
DOI:10.3389/fonc.2020.575317
|
|
|
|
|
[2]
|
Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
Journal of Oncology,
2020
DOI:10.1155/2020/4061063
|
|
|
|
|
[3]
|
Molecular characteristics of breast cancer according to clinicopathological factors
Molecular and Clinical Oncology,
2019
DOI:10.3892/mco.2019.1869
|
|
|
|
|
[4]
|
Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer
Annals of Diagnostic Pathology,
2017
DOI:10.1016/j.anndiagpath.2017.01.009
|
|
|
|
|
[5]
|
Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers
PLOS ONE,
2016
DOI:10.1371/journal.pone.0149661
|
|
|
|
|
[6]
|
Clinicopathological Characteristics of Triple Negative Breast Cancer at a Tertiary Care Hospital in India
Asian Pacific Journal of Cancer Prevention,
2015
DOI:10.7314/APJCP.2014.15.24.10577
|
|
|
|
|
[7]
|
Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging
Breast Cancer Research and Treatment,
2015
DOI:10.1007/s10549-015-3558-1
|
|
|
|
|
[8]
|
Correlation of CK5 and EGFR with Clinicopathological Profile of Triple-Negative Breast Cancer
Pathology Research International,
2014
DOI:10.1155/2014/141864
|
|
|
|